Subscribe To
Verve expands leadership team with appointment of frederick t. fiedorek, m.d., as chief medical officer
BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardio...
September 18, 2023, 10:30 am
Orchard therapeutics: a reassessment
Orchard Therapeutics plc is a London-based biotech company focused on developing gene therapies for rar...
September 18, 2023, 9:20 am
Should you invest in the spdr s&p biotech etf (xbi)?
If you're interested in broad exposure to the Healthcare - biotech segment of the equity market, look n...
September 18, 2023, 7:32 am
Triana biomedicines to present at ubs biotechnology private company virtual symposium
LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing a t...
September 18, 2023, 7:30 am
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of tengjun biotechnology corp. – tjbh
NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Tengjun Biotechnology Corp. (“Tengiun�...
September 18, 2023, 12:12 am
Enanta pharmaceuticals to present data for edp-323, its oral, once-daily, l-protein inhibitor in development for the treatment of respiratory syncytial virus, at the 9th eswi influenza conference
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating novel, sma...
September 17, 2023, 12:00 pm
Ixj: healthcare dashboard for september
The sector as a whole is overvalued by about 15% relative to 11-year averages. Healthcare providers and pharmaceuticals/biotechnology look fairly valu...
September 16, 2023, 8:26 am
Why shares of dyne therapeutics fell this week
Dyne Therapeutics is a clinical-stage biotech. The company focuses on rare genetic disorders....
September 15, 2023, 1:52 pm
Why shares of immunitybio jumped this week
The clinical-stage biotech's lead therapy is in trials to treat bladder cancer. The sale of company stock helped raise $470 million....
September 15, 2023, 12:52 pm
Better growth stock: recursion pharmaceuticals vs. crispr therapeutics
The timing of upcoming catalysts is a key consideration when comparing biotechs. Recursion Pharmaceuticals may make more revenue soon, but not from it...
September 15, 2023, 10:07 am
Why is axcella health (axla) stock down 24% today?
Axcella Health (NASDAQ: AXLA ) stock is taking a beating on Friday after the biotechnology company announced plans for a reverse stock split. Accordi...
September 15, 2023, 9:01 am
Why is moleculin biotech (mbrx) stock is moving today?
Moleculin Biotech (NASDAQ: MBRX ) stock is on the move Friday after the clinical-stage pharmaceutical company provided an update to investors. Accord...
September 15, 2023, 8:24 am
U.s. food and drug administration updates prescription drug user fee act (pdufa) action date for lifileucel for the treatment of advanced melanoma
Priority Review Continues with Successful Facility Inspections Completed,no Major Review Issues FDA Extends PDUFA Date to February 24, 2024 on Resourc...
September 14, 2023, 10:10 pm
Why aclaris therapeutics stock soared nearly 6% on thursday
An analyst raised his price target on the biotech. He also maintained his buy recommendation on the stock....
September 14, 2023, 7:03 pm
Bioxytran announces broad spectrum antiviral activity highlighted in prolectin-m
BOSTON, MASSACHUSETTS, Sept. 14, 2023 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company develop...
September 14, 2023, 1:41 pm
Gracell biotechnologies to participate in three upcoming investor conferences
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a gl...
September 14, 2023, 9:15 am
Nuclear magnetic resonance spectrometer market is expected to reach usd 1.05 billion by 2032, with a cagr of 5.50% from 2023 to 2032 – report by market research future (mrfr)
Nuclear Magnetic Resonance (NMR) Spectrometer Market Research Report Information Product (Instruments and Consumables), Type (Low-field (NMR) Spectros...
September 14, 2023, 8:26 am
Cancervax ceo ryan davies discusses the company’s growing pipeline of cancer treatments
The Company’s development pipeline now includes three projects with UCLA LEHI, Utah, Sept. 14, 2023 (GLOBE NEWSWIRE) — CancerVAX, Inc., a pre-clin...
September 14, 2023, 7:01 am
I-mab: why this company trades at a third the value of its cash
Chinese biotech company I-Mab faces challenges in attracting US capital due to lack of transparency and...
September 13, 2023, 4:59 pm
"blockbuster status": 3 bios to buy and hold
The biotech sector is notorious for its sky-high R&D costs, regulatory hurdles, and lengthy timelines t...
September 13, 2023, 3:47 pm